Search

everythinglearnresearchcommunity

for

Search:↓

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Using isotretinoin gel and minoxidil solution together effectively regrows hair in most people with patchy hair loss.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Researchers found four genes that could help diagnose severe alopecia areata early.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

A child's hair loss from alopecia areata was fully reversed in five months using diet and supplements.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Combining ciclosporin and simvastatin can cause severe kidney damage.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

AB+ blood group is more common in alopecia areata patients.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.